{"id":870873,"date":"2025-08-05T08:44:36","date_gmt":"2025-08-05T12:44:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/"},"modified":"2025-08-05T08:44:36","modified_gmt":"2025-08-05T12:44:36","slug":"liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/","title":{"rendered":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">MORRISVILLE, N.C., Aug.  05, 2025  (GLOBE NEWSWIRE) &#8212; Liquidia Corporation\u00a0(NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. The company will host a webcast at\u00a08:30 a.m. Eastern Time\u00a0to discuss its financial results and provide a corporate update.<\/p>\n<p>The webcast will be available on\u00a0Liquidia&#8217;s\u00a0website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SCQXBwmBlU8ZxIgul2-h1Xzteef7pU56HEc8XG-QzP-R7ntWz8npc5DT1HKuOVLr5HmdKswCp2TLuiYq1A_sg1O2A8IsUfIndJtIYSayUnxljwxN_dP4fuyunxbcDDrL7MXMTgh5rqVCOlsE4fO0XRUL_l8t4axo5ViSpMisCqLyarTvabJUipahlZfLoGUl\" rel=\"nofollow\" target=\"_blank\">https:\/\/liquidia.com\/investors\/events-and-presentations<\/a>. A rebroadcast of the event will be available and archived for a period of one year at the same location.<\/p>\n<p><strong>About\u00a0Liquidia Corporation<\/strong><br \/>Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT<sup>\u00ae<\/sup> Technology. PRINT enabled the creation of YUTREPIA\u2122 (treprostinil) inhalation powder, a drug that has been approved for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PHILD). The company is also developing L606, an investigational sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LTiQshvDjiAknDRe8Tp_2C8yrwy4MjdSRQ1KJXW93pLeaGMiabuJ8DgAGzxb88AEoeOPGATsjnu04EG49-DnGtfo93BwxPAlw85kR4hKdog=\" rel=\"nofollow\" target=\"_blank\">www.liquidia.com<\/a>.<\/p>\n<p><strong>Contact Information<\/strong><\/p>\n<p><strong>Investors:<\/strong><br \/>Jason Adair<br \/>Chief Business Officer<br \/>919.328.4350<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AGCSFQJa4lQyw6lI1x9YTVp51vp6rp95II7xOuo3Cywug8hSVP0_r-SLnSbfxAFMAlR3-1UePS_IxmdF2UfpU4OXRuciystD_XOGpuc6sG7R-xcsumVEZrgRGNTVT4yN\" rel=\"nofollow\" target=\"_blank\">jason.adair@liquidia.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cs13eGCHKZ4ODyMqWyMxr9vDXeC7hHs8UEznqTnLrf2ynoimm9zupZQSSouJ16_3Dh8MYo0Ps2u1uc4gC_3OkQQ2sEpucxD9VZoYXUEHy-Yrgx9UuRVOxjcBniQxf6yTyfk56tDpNvO_r91K9nTcbpwDePY_VKaqAcielwI6rsYncm2o2IIIGkgumkVwD7tdHI67mukDiPvGzkphkog1NeNJPhRvXbPRM9ISHcC9GP1RqsFBZ0UJOx39ecqoJ2XGuYV9DuIezFY5pgthtiE-G761HYj2PAPi30bR_rGfCf6voS6CQDtvb72xs1N_TJWukluSAnLPBTytlKJKjez51EDszL-gDJKeGsxhC0HPjir8jxx8qAeqsTJNYC9Mj1rkD_y2syBFJijpJAqLLHg99VjAbWPFsMINV-oREO3qLbbM9z-eaMk-QGzRD6XC8-JyL16SkVqMFIOJsaZPgbPRBQ==\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZYiQ5B65G2X1FOJ7zrryWyNJqvQMc-P7L9Ar7DFukkx--h0A0xAPy4z6255Qu4IZnfi3JB34ZS0d-OaN4_XuzY97Zd5jcbe9jqxkiRMhmi_qUm1y7fw8GxjiYDAFV4uMr42WlyTCi9vvll3qJmBrqHKIFRhhx5xu8ll-jeyjlCiTN3_W1ipmed8iZc-GgvMrcePT2UJxAuXxJeTwqJTDcimRbWuOGShtPZTR-mwc5rdv5tUIiC7mwcw0BbxvyWpe5NKyX1SbB3tmNL8v4z1ejeSkb4pYAulZfh4yurR053cW3g1T9XWGaRaBBQ6sQnubxfILYJakV5YMI1Yq4jYdu_8hAIEp3YfqVlj6XpqqasICC-0I1ADaxPmYG4wFhLeklUIpfdshSiwohELq-s2EgY9XmsRCPwnWR7v_Z9hsU6xV-uk6MGtl9XmPgzZ5EbOhTp1m6LJ68IMAq2zVbnea4w==\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a><strong>Media: <\/strong><br \/>Patrick Wallace<br \/>Director, Corporate Communications<br \/>919.328.4383<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EifI4vsaOm5YAuDXB6J32k1aVMKOuld7DO36Xy-a8YJw4_oAuIjixIEJRLPvtIfAFyVfEkx67UYlKPnlIaRzCvj6pdiNSiyTP1lZIQR6uT7DpQwkNioI0iHxxKkR8CPw\" rel=\"nofollow\" target=\"_blank\">patrick.wallace@liquidia.com<\/a><\/u><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDNmZDllMGEtZTU0Zi00OThlLTg1MDItYmUwNzFiNzE2ODA0LTEwOTYwMzEtMjAyNS0wOC0wNS1lbg==\/tiny\/Liquidia-Technologies-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation\u00a0(NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. The company will host a webcast at\u00a08:30 a.m. Eastern Time\u00a0to discuss its financial results and provide a corporate update. The webcast will be available on\u00a0Liquidia&#8217;s\u00a0website at\u00a0https:\/\/liquidia.com\/investors\/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About\u00a0Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870873","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation\u00a0(NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. The company will host a webcast at\u00a08:30 a.m. Eastern Time\u00a0to discuss its financial results and provide a corporate update. The webcast will be available on\u00a0Liquidia&#8217;s\u00a0website at\u00a0https:\/\/liquidia.com\/investors\/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About\u00a0Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of &hellip; Continue reading &quot;Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T12:44:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025\",\"datePublished\":\"2025-08-05T12:44:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/\"},\"wordCount\":234,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/\",\"name\":\"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\",\"datePublished\":\"2025-08-05T12:44:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/","og_locale":"en_US","og_type":"article","og_title":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk","og_description":"MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Liquidia Corporation\u00a0(NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. The company will host a webcast at\u00a08:30 a.m. Eastern Time\u00a0to discuss its financial results and provide a corporate update. The webcast will be available on\u00a0Liquidia&#8217;s\u00a0website at\u00a0https:\/\/liquidia.com\/investors\/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About\u00a0Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of &hellip; Continue reading \"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-05T12:44:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025","datePublished":"2025-08-05T12:44:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/"},"wordCount":234,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/","name":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=","datePublished":"2025-08-05T12:44:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNTU5NSM3MDgwMTAzIzIwODQ0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-report-second-quarter-2025-financial-results-on-august-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870873"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870873\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}